$ARLZ Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Old API Wind-down Ltd..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Old API Wind-down Ltd.. Get notifications about new insider transactions in Old API Wind-down Ltd. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 06 2018 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Sell | S | 0.37 | 156,573 | 58,590 | 1,183,419 | 1.3 M to 1.2 M (-11.68 %) |
| May 16 2018 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Sell | S | 0.52 | 13,964 | 7,261 | 1,339,992 | 1.4 M to 1.3 M (-1.03 %) |
| May 16 2018 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 0.52 | 9,348 | 4,882 | 242,052 | 251.4 K to 242.1 K (-3.72 %) |
| Mar 21 2018 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Sell | S | 1.70 | 3,471 | 5,901 | 198,093 | 201.6 K to 198.1 K (-1.72 %) |
| Mar 21 2018 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 1.70 | 5,950 | 10,115 | 251,400 | 257.4 K to 251.4 K (-2.31 %) |
| Mar 21 2018 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Sell | S | 1.70 | 9,739 | 16,556 | 1,353,956 | 1.4 M to 1.4 M (-0.71 %) |
| Mar 21 2018 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Sell | S | 1.70 | 5,725 | 9,733 | 250,188 | 255.9 K to 250.2 K (-2.24 %) |
| Mar 19 2018 | ARLZ | Aralez Pharmaceuti ... | Kaseta Michael | Chief Financial Off ... | Option Exercise | A | 1.75 | 25,000 | 43,750 | 25,000 | |
| Mar 19 2018 | ARLZ | Aralez Pharmaceuti ... | Kaseta Michael | Chief Financial Off ... | Grant | A | 0.00 | 12,500 | 0 | 15,000 | 2.5 K to 15 K (+500.00 %) |
| Dec 12 2017 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | P | 1.47 | 50,000 | 73,535 | 271,609 | 221.6 K to 271.6 K (+22.56 %) |
| Dec 04 2017 | ARLZ | Aralez Pharmaceuti ... | Kaseta Michael | Interim CFO | Option Exercise | A | 1.51 | 25,000 | 37,750 | 25,000 | |
| Oct 04 2017 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Sell | S | 2.50 | 9,960 | 24,918 | 257,350 | 267.3 K to 257.4 K (-3.73 %) |
| Jul 28 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Sell | S | 1.25 | 10,804 | 13,509 | 280,551 | 291.4 K to 280.6 K (-3.71 %) |
| Jul 28 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Sell | S | 1.25 | 10,804 | 13,509 | 280,551 | 291.4 K to 280.6 K (-3.71 %) |
| Jun 23 2017 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Sell | S | 1.33 | 7,720 | 10,268 | 201,564 | 209.3 K to 201.6 K (-3.69 %) |
| Jun 19 2017 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | P | 1.15 | 15,000 | 17,181 | 221,609 | 206.6 K to 221.6 K (+7.26 %) |
| Jun 16 2017 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | P | 1.17 | 50,000 | 58,525 | 206,609 | 156.6 K to 206.6 K (+31.93 %) |
| Jun 06 2017 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Sell | S | 1.28 | 161,906 | 207,110 | 1,363,695 | 1.5 M to 1.4 M (-10.61 %) |
| May 24 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Sell | S | 1.41 | 104,176 | 146,878 | 0 | 104.2 K to 0 (-100.00 %) |
| May 24 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Sell | S | 1.42 | 233,468 | 332,365 | 104,176 | 337.6 K to 104.2 K (-69.15 %) |
| May 24 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Sell | S | 1.56 | 51,041 | 79,558 | 337,644 | 388.7 K to 337.6 K (-13.13 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Option Exercise | A | 1.56 | 52,104 | 81,282 | 52,104 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Grant | A | 0.00 | 45,096 | 0 | 156,825 | 111.7 K to 156.8 K (+40.36 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Option Exercise | A | 1.56 | 96,121 | 149,949 | 96,121 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Grant | A | 0.00 | 83,192 | 0 | 291,355 | 208.2 K to 291.4 K (+39.96 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Option Exercise | A | 1.56 | 74,851 | 116,768 | 74,851 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Grant | A | 0.00 | 64,784 | 0 | 209,284 | 144.5 K to 209.3 K (+44.83 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | ADAMS ADRIAN | Chief Executive Off ... | Option Exercise | A | 1.56 | 252,316 | 393,613 | 252,316 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | ADAMS ADRIAN | Chief Executive Off ... | Grant | A | 0.00 | 218,380 | 0 | 3,787,610 | 3.6 M to 3.8 M (+6.12 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Option Exercise | A | 1.56 | 92,621 | 144,489 | 92,621 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Grant | A | 0.00 | 80,163 | 0 | 255,913 | 175.8 K to 255.9 K (+45.61 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 1.56 | 96,121 | 149,949 | 96,121 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 83,192 | 0 | 267,310 | 184.1 K to 267.3 K (+45.18 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & CBO | Option Exercise | A | 1.56 | 126,158 | 196,806 | 126,158 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & CBO | Grant | A | 0.00 | 109,190 | 0 | 1,525,601 | 1.4 M to 1.5 M (+7.71 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | thrasher francis martin | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | thrasher francis martin | Director | Grant | A | 0.00 | 7,500 | 0 | 19,365 | 11.9 K to 19.4 K (+63.21 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Grant | A | 0.00 | 7,500 | 0 | 86,891 | 79.4 K to 86.9 K (+9.45 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 7,500 | 0 | 102,952 | 95.5 K to 103 K (+7.86 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Grant | A | 0.00 | 7,500 | 0 | 601,594 | 594.1 K to 601.6 K (+1.26 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Grant | A | 0.00 | 7,500 | 0 | 156,609 | 149.1 K to 156.6 K (+5.03 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Grant | A | 0.00 | 7,500 | 0 | 73,869 | 66.4 K to 73.9 K (+11.30 %) |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Option Exercise | A | 1.56 | 15,000 | 23,400 | 15,000 | |
| May 12 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Grant | A | 0.00 | 7,500 | 0 | 15,000 | 7.5 K to 15 K (+100.00 %) |
| Apr 25 2017 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Buy | P | 5.86 | 295,929 | 1,732,664 | 343,216 | 47.3 K to 343.2 K (+625.81 %) |
| Mar 22 2017 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Sell | S | 2.41 | 5,205 | 12,544 | 208,163 | 213.4 K to 208.2 K (-2.44 %) |
| Mar 22 2017 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Sell | S | 2.41 | 7,825 | 18,858 | 1,416,411 | 1.4 M to 1.4 M (-0.55 %) |
| Dec 12 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Gift | G | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| Dec 12 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Gift | G | 0.00 | 30,000 | 0 | 64,391 | 94.4 K to 64.4 K (-31.78 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | M | 3.92 | 104,778 | 410,730 | 0 | |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | M | 3.92 | 20,000 | 78,400 | 104,778 | |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 4.99 | 104,778 | 523,146 | 594,094 | 698.9 K to 594.1 K (-14.99 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Buy | M | 3.92 | 104,778 | 410,730 | 698,872 | 594.1 K to 698.9 K (+17.64 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 4.65 | 20,000 | 93,000 | 594,094 | 614.1 K to 594.1 K (-3.26 %) |
| Nov 30 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Buy | M | 3.92 | 20,000 | 78,400 | 614,094 | 594.1 K to 614.1 K (+3.37 %) |
| Nov 15 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Buy | P | 4.77 | 30,000 | 143,121 | 94,391 | 64.4 K to 94.4 K (+46.59 %) |
| Nov 15 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Buy | P | 4.95 | 1,000 | 4,950 | 90,452 | 89.5 K to 90.5 K (+1.12 %) |
| Sep 19 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 6.04 | 75,000 | 453,218 | 594,094 | 669.1 K to 594.1 K (-11.21 %) |
| Sep 19 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Sell | S | 5.60 | 75,000 | 420,000 | 669,094 | 744.1 K to 669.1 K (-10.08 %) |
| Jun 24 2016 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Payment of Exercise | F | 3.34 | 10,803 | 36,082 | 175,750 | 186.6 K to 175.8 K (-5.79 %) |
| Jun 24 2016 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Payment of Exercise | F | 3.34 | 6,850 | 22,879 | 111,729 | 118.6 K to 111.7 K (-5.78 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | thrasher francis martin | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | thrasher francis martin | Director | Grant | A | 0.00 | 7,500 | 0 | 11,865 | 4.4 K to 11.9 K (+171.82 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Grant | A | 0.00 | 7,500 | 0 | 89,452 | 82 K to 89.5 K (+9.15 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Grant | A | 0.00 | 7,500 | 0 | 66,369 | 58.9 K to 66.4 K (+12.74 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Aryeh Jason | Director | Grant | A | 0.00 | 7,500 | 0 | 7,500 | 0 to 7.5 K |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Harris Robert Paul | Director | Grant | A | 0.00 | 7,500 | 0 | 744,094 | 736.6 K to 744.1 K (+1.02 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Grant | A | 0.00 | 7,500 | 0 | 64,391 | 56.9 K to 64.4 K (+13.18 %) |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Option Exercise | A | 3.42 | 15,000 | 51,300 | 15,000 | |
| Jun 20 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Grant | A | 0.00 | 7,500 | 0 | 104,109 | 96.6 K to 104.1 K (+7.76 %) |
| Jun 15 2016 | ARLZ | Aralez Pharmaceuti ... | thrasher francis martin | Director | Option Exercise | M | 2.82 | 4,365 | 12,309 | 0 | |
| Jun 15 2016 | ARLZ | Aralez Pharmaceuti ... | thrasher francis martin | Director | Buy | M | 2.82 | 4,365 | 12,309 | 277,178 | 272.8 K to 277.2 K (+1.60 %) |
| Jun 14 2016 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Payment of Exercise | F | 3.58 | 1,251 | 4,479 | 49,479 | 50.7 K to 49.5 K (-2.47 %) |
| Jun 14 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Payment of Exercise | F | 3.58 | 1,404 | 5,026 | 81,952 | 83.4 K to 82 K (-1.68 %) |
| Jun 07 2016 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Payment of Exercise | F | 3.97 | 206,070 | 818,098 | 1,404,236 | 1.6 M to 1.4 M (-12.80 %) |
| May 23 2016 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Buy | P | 3.75 | 10,000 | 37,500 | 179,368 | 169.4 K to 179.4 K (+5.90 %) |
| May 18 2016 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Buy | P | 3.68 | 25,000 | 92,050 | 186,553 | 161.6 K to 186.6 K (+15.47 %) |
| May 18 2016 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Buy | P | 3.79 | 4,500 | 17,037 | 169,368 | 164.9 K to 169.4 K (+2.73 %) |
| May 18 2016 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Buy | P | 3.76 | 10,000 | 37,570 | 144,500 | 134.5 K to 144.5 K (+7.43 %) |
| May 17 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Buy | P | 3.50 | 1,000 | 3,500 | 83,356 | 82.4 K to 83.4 K (+1.21 %) |
| May 16 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | P | 3.49 | 5,000 | 17,450 | 5,000 | 0 to 5 K |
| May 16 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | P | 3.49 | 22,500 | 78,548 | 96,609 | 74.1 K to 96.6 K (+30.36 %) |
| May 16 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Buy | P | 3.49 | 50,000 | 174,495 | 213,368 | 163.4 K to 213.4 K (+30.61 %) |
| May 13 2016 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Buy | P | 3.49 | 71,500 | 249,471 | 1,610,306 | 1.5 M to 1.6 M (+4.65 %) |
| Apr 07 2016 | ARLZ | Aralez Pharmaceuti ... | QLT INC/BC | 10% Owner | Sell | S | 6.25 | 2,400,000 | 15,000,000 | 4,800,000 | 7.2 M to 4.8 M (-33.33 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial of ... | Option Exercise | A | 3.80 | 38,559 | 146,524 | 38,559 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial of ... | Grant | A | 0.00 | 45,553 | 0 | 161,553 | 116 K to 161.6 K (+39.27 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Option Exercise | A | 3.80 | 40,096 | 152,365 | 40,096 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Grant | A | 0.00 | 47,368 | 0 | 163,368 | 116 K to 163.4 K (+40.83 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Option Exercise | A | 3.80 | 29,203 | 110,971 | 29,203 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, CCO & Secretary | Grant | A | 0.00 | 34,500 | 0 | 134,500 | 100 K to 134.5 K (+34.50 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | ADAMS ADRIAN | Chief Executive Off ... | Option Exercise | A | 3.80 | 105,251 | 399,954 | 105,251 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | ADAMS ADRIAN | Chief Executive Off ... | Grant | A | 0.00 | 124,342 | 0 | 3,069,230 | 2.9 M to 3.1 M (+4.22 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Option Exercise | A | 3.80 | 26,730 | 101,574 | 26,730 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Grant | A | 0.00 | 31,579 | 0 | 118,579 | 87 K to 118.6 K (+36.30 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Option Exercise | A | 3.80 | 52,592 | 199,850 | 52,592 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Grant | A | 0.00 | 62,132 | 0 | 1,538,806 | 1.5 M to 1.5 M (+4.21 %) |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Option Exercise | A | 3.80 | 40,096 | 152,365 | 40,096 | |
| Mar 18 2016 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 47,368 | 0 | 164,868 | 117.5 K to 164.9 K (+40.31 %) |
| Feb 17 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Grant | A | 0.00 | 86,863 | 0 | 116,000 | 29.1 K to 116 K (+298.12 %) |
| Feb 17 2016 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | GC, COO & Secretary | Grant | A | 0.00 | 75,000 | 0 | 100,000 | 25 K to 100 K (+300.00 %) |
| Feb 17 2016 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Grant | A | 0.00 | 65,147 | 0 | 87,000 | 21.9 K to 87 K (+298.11 %) |
| Feb 17 2016 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Grant | A | 0.00 | 86,863 | 0 | 116,000 | 29.1 K to 116 K (+298.12 %) |
| Feb 17 2016 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Grant | A | 0.00 | 86,863 | 0 | 117,500 | 30.6 K to 117.5 K (+283.52 %) |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | KOVEN ANDREW I | President & Chief B ... | Buy | J | 0.00 | 1,476,674 | 0 | 1,476,674 | 0 to 1.5 M |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Option Exercise | J | 13.26 | 6,107 | 80,979 | 6,107 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | LEE KENNETH B JR | Director | Buy | J | 0.00 | 72,966 | 0 | 72,966 | 0 to 73 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Armstrong Jennifer Lou | EVP HR and Administ ... | Buy | J | 0.00 | 21,853 | 0 | 21,853 | 0 to 21.9 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Tursi James Patrick | Chief Medical Offic ... | Buy | J | 0.00 | 30,637 | 0 | 30,637 | 0 to 30.6 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | ADAMS ADRIAN | Chief Executive Off ... | Buy | J | 0.00 | 2,944,888 | 0 | 2,944,888 | 0 to 2.9 M |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Glickman Mark A | Chief Commercial Of ... | Buy | J | 0.00 | 29,137 | 0 | 29,137 | 0 to 29.1 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Trachtenberg Eric | General Counsel, CO ... | Buy | J | 0.00 | 25,000 | 0 | 25,000 | 0 to 25 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | RUDNICK SETH | Director | Buy | J | 0.00 | 47,501 | 0 | 47,501 | 0 to 47.5 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Charles Scott J | Chief Financial Off ... | Buy | J | 0.00 | 29,137 | 0 | 29,137 | 0 to 29.1 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Fowler Neal Franklin | Director | Buy | J | 0.00 | 50,730 | 0 | 50,730 | 0 to 50.7 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Option Exercise | J | 6.35 | 6,107 | 38,779 | 6,107 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Option Exercise | J | 11.83 | 6,107 | 72,246 | 6,107 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Option Exercise | J | 13.26 | 6,107 | 80,979 | 6,107 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | J | 0.00 | 64,719 | 0 | 64,719 | 0 to 64.7 K |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance and Adm ... | Option Exercise | J | 3.87 | 9,161 | 35,453 | 9,161 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance and Adm ... | Option Exercise | J | 11.83 | 15,757 | 186,405 | 15,757 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance and Adm ... | Option Exercise | J | 8.36 | 14,658 | 122,541 | 14,658 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance and Adm ... | Option Exercise | J | 13.84 | 41,195 | 570,139 | 41,195 | |
| Feb 09 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance and Adm ... | Buy | J | 0.00 | 75,528 | 0 | 75,528 | 0 to 75.5 K |
| Feb 08 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance & Admin ... | Option Exercise | M | 1.98 | 2,036 | 4,031 | 0 | |
| Feb 08 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance & Admin ... | Payment of Exercise | F | 6.57 | 614 | 4,034 | 75,528 | 76.1 K to 75.5 K (-0.81 %) |
| Feb 08 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance & Admin ... | Buy | M | 1.98 | 2,036 | 4,031 | 76,142 | 74.1 K to 76.1 K (+2.75 %) |
| Feb 08 2016 | ARLZ | Aralez Pharmaceuti ... | BARNHARDT JOHN E | VP, Finance & Admin ... | Payment of Exercise | F | 6.57 | 13,682 | 89,891 | 74,106 | 87.8 K to 74.1 K (-15.59 %) |
| Feb 08 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Option Exercise | M | 5.97 | 6,107 | 36,459 | 0 | |
| Feb 08 2016 | ARLZ | Aralez Pharmaceuti ... | Kirsch Arthur S | Director | Buy | M | 5.97 | 6,107 | 36,459 | 64,719 | 58.6 K to 64.7 K (+10.42 %) |
Page: 1